awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38676172-693A94D2-8C0B-4090-9453-6268226FA393
Q38676172-693A94D2-8C0B-4090-9453-6268226FA393
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38676172-693A94D2-8C0B-4090-9453-6268226FA393
Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
P2860
Q38676172-693A94D2-8C0B-4090-9453-6268226FA393
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38676172-693A94D2-8C0B-4090-9453-6268226FA393
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
41daedeafb502c092053f71f2e43b729f3331fb5
P2860
PO-41 - Rivaroxaban is effective therapy for high risk cancer patients with venous thromboembolic disease.